Comparison of Tumor-Associated Vasculatures in Uveal and Cutaneous Melanomas
暂无分享,去创建一个
[1] Takami Sato,et al. The biology and management of uveal melanoma , 2008, Current oncology reports.
[2] R. Folberg,et al. Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography , 2008, Eye.
[3] C. Shields. The hunt for the secrets of uveal melanoma , 2008, Clinical & experimental ophthalmology.
[4] R. Folberg,et al. Comparing Vasculogenic Mimicry With Endothelial Cell-lined Vessels: Techniques for 3D Reconstruction and Quantitative Analysis of Tissue Components from Archival Paraffin Blocks , 2007, Applied immunohistochemistry & molecular morphology : AIMM.
[5] R. Folberg,et al. Distinguishing fibrovascular septa from vasculogenic mimicry patterns. , 2005, Archives of pathology & laboratory medicine.
[6] M. Detmar,et al. Angiogenesis and lymphangiogenesis of skin cancers. , 2004, Hematology/oncology clinics of North America.
[7] R. Folberg,et al. Vasculogenic mimicry , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[8] M. Burnier,et al. Pathological and prognostic features of uveal melanomas. , 2004, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[9] T. Kivelä,et al. Microvascular loops and networks in uveal melanoma. , 2004, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[10] D. Massi,et al. Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma. , 2004, Human pathology.
[11] Loretta Auvil,et al. Three-dimensional reconstruction of extravascular matrix patterns and blood vessels in human uveal melanoma tissue: techniques and preliminary findings. , 2003, Investigative ophthalmology & visual science.
[12] E. Versteeg,et al. Localization and characterization of melanoma-associated glycosaminoglycans: differential expression of chondroitin and heparan sulfate epitopes in melanoma. , 2003, Cancer research.
[13] Michael Streit,et al. Angiogenesis, lymphangiogenesis, and melanoma metastasis , 2003, Oncogene.
[14] J. Diamond,et al. Multi-Vesicular Release From Mammalian Rod Bipolar Cell Terminals , 2003 .
[15] I. Grierson,et al. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. , 2003, Investigative ophthalmology & visual science.
[16] Robert Folberg,et al. Control of Melanoma Morphogenesis, Endothelial Survival, and Perfusion by Extracellular Matrix , 2002, Laboratory Investigation.
[17] D. Ruiter,et al. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. , 2002, Investigative ophthalmology & visual science.
[18] Mehdi Nosrati,et al. Tumor vascularity in the prognostic assessment of primary cutaneous melanoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] P. Meltzer,et al. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. , 2001, Cancer research.
[20] R Folberg,et al. Vasculogenic mimicry and tumor angiogenesis. , 2000, The American journal of pathology.
[21] A. Tarkkanen,et al. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. , 1999, Investigative ophthalmology & visual science.
[22] P. Meltzer,et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.
[23] G. Yancopoulos,et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.
[24] K. Alitalo,et al. Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression. , 1999, Melanoma research.
[25] R. Folberg,et al. Microcirculation architecture of metastases from primary ciliary body and choroidal melanomas. , 1998, American journal of ophthalmology.
[26] M. Nowak,et al. Glycogen-rich malignant melanomas and glycogen-rich balloon cell malignant melanomas: frequency and pattern of PAS positivity in primary and metastatic melanomas. , 1998, Archives of pathology & laboratory medicine.
[27] S. Seregard,et al. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma. , 1998, Ophthalmology.
[28] M. Burnier,et al. Uveal melanoma: Comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type, and tumor size , 1997 .
[29] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.
[30] K. Daniels,et al. Expression of type VI collagen in uveal melanoma: its role in pattern formation and tumor progression. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[31] S. Fox,et al. TUMOUR ANGIOGENESIS , 1996, The Journal of pathology.
[32] N. Bornfeld,et al. Prognostic implications of monosomy 3 in uveal melanoma , 1996, The Lancet.
[33] Y. Ohnishi,et al. Histologic findings and prognosis of uveal malignant melanoma in japanese patients. , 1996, American journal of ophthalmology.
[34] A. Cochran,et al. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. , 1995, The American journal of pathology.
[35] D. Duval,et al. 9 Tumour angiogenesis , 1993 .
[36] R. Folberg,et al. The morphologic characteristics of tumor blood vessels as a marker of tumor progression in primary human uveal melanoma: a matched case-control study. , 1992, Human pathology.
[37] M. Mihm,et al. Angiogenesis and regressing cutaneous malignant melanoma , 1992, The Lancet.
[38] J. Hemet,et al. Possible association of erythema multiforme with acamprosate , 1992, The Lancet.
[39] G. Westbury,et al. The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness. , 1991, British Journal of Cancer.
[40] A. Srivastava,et al. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. , 1988, The American journal of pathology.
[41] J. Folkman. What is the role of angiogenesis in metastasis from cutaneous melanoma? , 1987, European journal of cancer & clinical oncology.
[42] A. Srivastava,et al. Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. , 1986, European journal of cancer & clinical oncology.
[43] J. Shields,et al. Cobalt plaque therapy of posterior uveal melanomas. , 1982, Ophthalmology.
[44] M Goitein,et al. Proton Beam Irradiation: An Alternative to Enucleation for Intraocular Melanomas , 1980 .
[45] J. Wolf,et al. Melanoma. Tumor angiogenesis and human neoplasia , 1976, Cancer.
[46] J. Wolf,et al. Tumor angiogenic factor and human skin tumors. , 1975, Archives of dermatology.
[47] J. Folkman. Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.
[48] P. Shubik,et al. The growth of the blood supply to melanoma transplants in the hamster cheek pouch. , 1966, Laboratory investigation; a journal of technical methods and pathology.
[49] I. McLean. The biology of haematogenous metastasis in human meal malignant melanoma , 2005, Virchows Archiv A.
[50] Xiulan Zhao,et al. [Study on vasculogenic mimicry in malignant melanoma]. , 2003, Zhonghua bing li xue za zhi = Chinese journal of pathology.
[51] Taylor Murray,et al. Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.
[52] M. Goldbaum,et al. Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy. , 1998, Archives of ophthalmology.
[53] L. M. Gardner,et al. The microcirculation of choroidal and ciliary body melanomas , 1997, Eye.
[54] D. Hanahan,et al. Switch to the angiogenic phenotype during tumorigenesis. , 1991, Princess Takamatsu symposia.
[55] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.